The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Briumvi Accelagen Pty Ltd
Product name
Briumvi
Sponsor
Accepted date
Jul-2024
Active ingredients
ublituximab
Proposed indication
For the treatment of relapsing forms of multiple sclerosis
Application type
A (new medicine)
Publication date
Jul-2024